Vycor Medical Inc
VYCO· OTC
VYCOVycor Medical Inc
Filed Nov 13, 2018 · 10-Q · 44 days after period end · 0001493152-18-015662
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $456.21K | $379.07K | $325.78K | $242.86K |
| Net Income | -$152.18K | -$428.40K | -$331.90K | -$506.79K |
| EPS Diluted | -$0.01 | -$0.03 | -$0.04 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Nov 13, 2018 · 44 d after period end
